Epigenomics AG EPGNF:OTCPK

*Data is delayed | Exchange | USD
Last | 11/29/23 EDT
0.50UNCH (UNCH)
52 week range
0.50 - 4.65
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.50
  • 52 Week High4.65
  • 52 Week High Date07/27/23
  • 52 Week Low0.50
  • 52 Week Low Date11/29/23

Key Stats

  • Market Cap1.49M
  • Shares Out853,285.81
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.50
  • 52 Week High4.65
  • 52 Week High Date07/27/23
  • 52 Week Low0.50
  • 52 Week Low Date11/29/23
  • Market Cap1.49M
  • Shares Out853,285.81
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-21.38
  • P/E (TTM)-0.02
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Epigenomics AG

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The Company's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product...
Andrew Lukowiak Ph.D.
President, Chief Scientific Officer
Jens Ravens
Chief Financial Officer
Address
Geneststrasse 5
Berlin
10829
Germany